Mediolanum looks set for takeoff

Article Abstract:

Mediolanum SpA received a favorable rating from Standard & Poor and analysts predict its shares increasing by 25% before the end of the year.

Life Insurance, Direct Life Insurance Carriers, Financial analysis, Evaluation, Insurance industry, Life insurance industry, Mediolanum S.p.A.

---

Fiat outlines strategy for auto division, will seek opportunities for acquisitions

Article Abstract:

Fiat SpA's chief executive Paolo Cantarella said that his company's auto division is expected to be profitable again by the fourth quarter of 1999. Mr. Cantarella said that Fiat has $10 billion for investments in acquisitions or in other sectors of the group. During the first quarter of 1999, the car maker posted a 211 billion Italian lire ($115.5 million) loss. Fiat also posted an 84% drop in pretax profits for the period.

Comment:

Auto division expected to be profitable again by fourth quarter of 1999

Sales, profits & dividends, Motor Vehicles, Automobile and Light Duty Motor Vehicle Manufacturing, Finance, Abstract, Automobile industry, Fiat S.p.A.

---

Intesa board says bank will buy CariPharma stake

Article Abstract:

Italy-based Banca Intesa SpA'a board agreed recently to buy the remaining 23.4% of Italy-based savings bank Cassa di Risparmio di Pharma e Placenza (CariPharma)

United States, Commercial Banks, Commercial Banking, Asset sales & divestitures, Acquisitions & mergers, Banking industry, Mergers, acquisitions and divestments, Banca Intesa S.p.A., Cassa di Risparmio di Pharma e Placenza

Similar abstracts:

• Abstracts: Mattel pursues sale of Learning Co. to end saga of troubled acquisition. Inprise and Corel agree to call off their merger plan
• Abstracts: US Navy extends work supporting sensors for littoral operations. US Navy aims to get Orion/Aries replacement under way
• Abstracts: DuPont's net income increase buoyed by Herberts acquisition. Anheuser-Busch reports 9.8% rise in its net income
• Abstracts: Lockheed Martin's earnings fell 37% for third quarter, beating forecasts. Lockheed Martin swung to a profit in first-quarter
• Abstracts: Pfizer to sell incontinence drug to defuse competition concerns. Elan shopping spree in U.S. nets Dura Pharmaceuticals

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.